aTYR PHARMA INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
aTYR PHARMA INC quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2024.
  • aTYR PHARMA INC Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $7.73M, a 84.4% decline year-over-year.
  • aTYR PHARMA INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $66.2M, a 1115% increase from 2022.
  • aTYR PHARMA INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $5.45M, a 95% decline from 2021.
  • aTYR PHARMA INC annual Net Cash Provided by (Used in) Financing Activities for 2021 was $110M, a 582% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7.73M -$41.8M -84.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $49.5M +$48M +3242% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $1.48M -$23.4M -94% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $24.9M +$8.08M +48.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $16.8M +$17.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 -$619K -$8.62M -108% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.